MFAP2 and obesity disorder: Since it is widely recognized that chronic low-grade inflammation is a cardinal feature of CC local progression enhancement, we next evaluated whether well-known inflammation-related factors dysregulated in obesity influence MFAP2 expression in HT-29 cells.